Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma

NCT06873269 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Hepatocellular Carcinoma
Liver Cirrhosis
Non-metastatic Hepatocellular Carcinoma

Interventions

OTHER: Baseline assessment
RADIATION: holmium-166 radioembolization
OTHER: Follow-up phase

Sponsor

Universitair Ziekenhuis Brussel